Built on deep insights into disease biology, NeuroVanda focuses on the development of transformational oral therapies targeting the most important drivers of neurodegenerative diseases. We have established a proprietary targeted protein degradation platform leveraging a differentiated E3 ligase which offers superior selectivity and efficiency in clearing aggregated proteins.